Park J, Middlekauff HR, Campese VM
Muscle Sympathetic Nerve Activity Is Elevated in Overweight
Individuals.
ASN Annual Meeting -- San Francisco
J Am Soc Nephrol
(Nov) 18:628A 2007

Background: Overweight individuals (BMI 25-29.9) are at higher risk for
cardiovascular and renal disease when compared to individuals of normal
weight (BMI 18.5-24.9). Although sympathetic nervous system (SNS) activity
has consistently been shown to be elevated in both normotensive and
hypertensive obese individuals (BMI
30), it is
unknown if overweight individuals, with a lesser degree of excess weight,
also have heightened SNS activity. In this study, we compared muscle
sympathetic nerve activity (MSNA) in overweight individuals versus normal-
weight individuals.
Methods: In 10 healthy controls of normal weight
and 5 healthy age-matched overweight individuals without hypertension, we
measured muscle sympathetic nerve activity (MSNA) by microneurography, body
mass index (BMI), blood pressure (BP), and heart rate (HR).
Results:
As expected, the mean BMI in the overweight group (26.9) was higher than that
of normal-weight controls (21.7). MSNA reported as bursts per minute was
significantly higher (P=0.0042) in overweight individuals (35.32
5.76) compared to controls (18.82
1.89). HR (overweight vs. controls, 79.9
4.0 versus 68.7
2.1, P=0.0171), SBP (132.4
mmHg versus 111.4
mmHg, P=0.0048), and DBP (73.4
mmHg versus 63.2
mmHg, P=0.0563) were higher in overweight individuals when compared to
controls.
Conclusions: MSNA and BP are significantly higher in
overweight individuals compared to normal-weight individuals. Heightened SNS
activity may contribute to increased BP and cardiovascular risk in overweight
as well as in obese subjects.
The poster for this
abstract is available for viewing. YOU MUST SIGN IN FIRST at the ASN Posters2View
website: (you need to type in a separate username and password of
your choosing). If you are not signed in, the direct link to the poster
below will not work!
Once signed in, you can access the poster
for this abstract directly at this
link.
Disclaimer: Abstracts often have errors, both
typographical and otherwise. This posting is an electronic translation of
submitted abstracts which has not been verified against the original
submitted abstract nor with the authors for accuracy. As a result, there
may be errors, especially with regard to drug doses, but not limited to
these. Abstracts undergo only limited review, and data often are changed
as a result of the peer review process, so their reliability is less than
manuscripts published in peer-reviewed journals. In using these
summaries, you are agreeing that you are aware of these limitations.
The materials are provided on an as-is basis without any warranty of
any kind, either express or implied. In addition to errors, the
information presented may be incomplete or outdated.
The information contained is not intended nor recommended as a substitute
for professional medical advice. You are advised to check the appropriate
medical literature and the product information currently provided by the
manufacturer of each device to be used or drug to be administered to
verify the dosage, the method and duration of administration, or
contraindications. It is the responsibility of the treating physician or
other health care professional, relying on independent experience and
knowledge of the patient, to determine drug, disease, and the best
treatment for the patient.
To the fullest extent permitted by law, HDCN, ASN and their affiliates and
suppliers disclaim all
warranties, express or implied, including, but not limited to, any
warranty of merchantability, non- infringement or fitness for a
particular purpose.
In no event shall HDCN, ASN, or their affiliates or suppliers be
liable for any damages whatsoever (including, but not limited to,
direct, indirect, incidental, consequential, punitive or exemplary
damages, or any damages for loss of profits, use, data, goodwill or
other intangibles) arising from or in any way relating to these terms,
the materials, or any information, goods or services obtained from or
referred to in the materials, whether based on warranty, contract, tort
(including, but not limited to, negligence), or any other legal theory,
and whether or not any or all of the limited entities is advised of the
possibility of such damages.
|